Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation

AA Gibb, MP Lazaropoulos, JW Elrod - Circulation research, 2020 - Am Heart Assoc
Cardiac fibrosis is mediated by the activation of resident cardiac fibroblasts, which
differentiate into myofibroblasts in response to injury or stress. Although myofibroblast …

Hypoxia signaling in human diseases and therapeutic targets

JW Lee, J Ko, C Ju, HK Eltzschig - Experimental & molecular medicine, 2019 - nature.com
Since the discovery of hypoxia-inducible factor (HIF), numerous studies on the hypoxia
signaling pathway have been performed. The role of HIF stabilization during hypoxia has …

Targeting metabolic dysregulation for fibrosis therapy

X Zhao, JYY Kwan, K Yip, PP Liu, FF Liu - Nature reviews Drug …, 2020 - nature.com
Fibrosis is the abnormal deposition of extracellular matrix, which can lead to organ
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …

Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation

H Cui, N Xie, S Banerjee, J Ge, D Jiang… - American Journal of …, 2021 - atsjournals.org
Augmented glycolysis due to metabolic reprogramming in lung myofibroblasts is critical to
their profibrotic phenotype. The primary glycolysis byproduct, lactate, is also secreted into …

[HTML][HTML] Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis

M Bueno, J Calyeca, M Rojas, AL Mora - Redox biology, 2020 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of unknown etiology. It is
characterized by deposition of extracellular matrix proteins, like collagen and fibronectin in …

HIF‐1α ameliorates tubular injury in diabetic nephropathy via HO‐1–mediated control of mitochondrial dynamics

N Jiang, H Zhao, Y Han, L Li, S Xiong, L Zeng… - Cell …, 2020 - Wiley Online Library
Objectives In diabetic nephropathy (DN), hypoxia‐inducible factor‐1α (HIF‐1α) activation in
tubular cells plays an important protective role against kidney injury. The effects may occur …

[HTML][HTML] Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

S Ravassa, B López, TA Treibel, G San José… - Molecular Aspects of …, 2023 - Elsevier
Heart failure is a leading cause of mortality and hospitalization worldwide. Cardiac fibrosis,
resulting from the excessive deposition of collagen fibers, is a common feature across the …

Fibrometabolism—An emerging therapeutic frontier in pulmonary fibrosis

B Selvarajah, I Azuelos, D Anastasiou… - Science Signaling, 2021 - science.org
Fibrosis is the final pathological outcome and major cause of morbidity and mortality in many
common and chronic inflammatory, immune-mediated, and metabolic diseases. Despite the …

[HTML][HTML] Dysregulation of metabolic pathways in pulmonary fibrosis

R Rajesh, R Atallah, T Bärnthaler - Pharmacology & Therapeutics, 2023 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder of unknown origin and
the most common interstitial lung disease. It progresses with the recruitment of fibroblasts …

Fibroblast senescence in idiopathic pulmonary fibrosis

Y Lin, Z Xu - Frontiers in Cell and Developmental Biology, 2020 - frontiersin.org
Aging is an inevitable and complex natural phenomenon due to the increase in age. Cellular
senescence means a non-proliferative but viable cellular physiological state. It is the basis of …